Abstract
A systematic review of matched cohort and case-control studies was performed to examine the mortality attributable to candidemia. The review included studies that compared mortality of patients with candidemia (cases) to that of matched patients without candidemia (controls). Secondary variables examined were the length and cost of hospital stay. Relevant studies were identified using the PubMed database and by examining the references of the initially selected studies. Two independent reviewers performed the literature search, study selection and data extraction from the identified studies. A total of seven studies were included in the review. The patients included those hospitalized in intensive care units (ICU) and hospital wards and those undergoing transplantation. The mortality attributed to candidemia in the reviewed studies ranged from 5 to 71%. For six of the reviewed studies the difference in mortality between cases and controls was statistically significant. Among those who survived, the length of stay and the cost of hospitalization of patients with candidemia were significantly higher than those of controls. Despite the methodological heterogeneity of the reviewed studies, the data from the available matched cohort and case-control studies suggest that candidemia is associated with considerable mortality that is attributed, at least to some degree, to the infection itself and not only to the presence of another comorbidity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP, National Nosocomial Infections Surveillance System Hospitals (2002) Secular trends of hospital-acquired candidemia among intensive care unit patients in the United States during 1989–1999. Clin Infect Dis 35:627–630
National Nosocomial Infection Surveillance (NNIS) (1999) System report, data summary from January1990–May 1999, issued June 1999. Am J Infect Control 27:520–532
Beck-Sague C, Jarvis WR (1993) Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990: National Nosocomial Infection Surveillance System. J Infect Dis 167:1247–1251
Edmond MB, Wallace SE, McClisch DK, Pfaller MA, Jones RN, Wenzel RP (1999) Nosocomial bloodstream infections in the United States hospitals: a three-year analysis. Clin Infect Dis 29:239–244
Caroll K, Jeppson K, Reading J, Reimer L (1993) Factors influencing outcome in hospitalized patients with candidemia. Infect Dis Clin Pract 2:268–271
Jarvis WR (1995) Epidemiology of nosocomial fungal infections with emphasis on Candida species. Clin Infect Dis 20:1526–1530
Pfaller M, Wenzel P (1992) Impact of changing epidemiology of fungal infections in the 1990s. Eur J Clin Micribiol Infect Dis 11:287–291
Wenzel RP (1995) Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis 20:1531–1534
Morgan J, Meltzer MI, Plikaytis BD, Sofair AN, Huie-White S, Wilcox S, Harrison LH, Seaberg EC, Hajjeh RA, Teutsh SM (2005) Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol 26:540–547
Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C (2005) The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 41:1232–1239
Blot SI, Vandewoude KH, Hoste EA, Colardyn FA (2002) Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 113:480–485
Gudlaugsson O, Gillespie S, Lee K, Berg JV, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D (2003) Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 37:1172–1177
Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP (1988) Hospital acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med 148:2642–2645
Nieto-Rodriguez JA, Kusne S, Mañez R, Irish W, Linden P, Magnone M, Wing EJ, Fung JJ, Starzl TE (1996) Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients. Ann Surg 223:70–76
Puzniak L, Teutsch S, Powderly W, Polish L (2004) Has the epidemiology of nosocomial candidemia changed? Infect Control Hosp Epidemiol 25:628–633
DiGiovine B, Chenoweth C, Watts C, Higgins M (1999) The attributable mortality and costs of primary nosocomial blood stream infections in the intensive care unit. Am J Respir Crit Care Med 160:976–981
Morrell M, Fraser VJ, Kollef MH (2005) Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49:3640–3645
Blot SI, Vandewounde KH (2003) Estimating attributable mortality of candidemia: clinical judgement vs. matched cohort studies. Eur J Clin Micribiol Infect Dis 22:132–133
Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, Edwards JE, Infectious Diseases Society of America (2004) Guidelines from the Infectious Diseases Society of America: guidelines for treatment of candidiasis. Clin Infect Dis 38:161–189
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Falagas, M.E., Apostolou, K.E. & Pappas, V.D. Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies. Eur J Clin Microbiol Infect Dis 25, 419–425 (2006). https://doi.org/10.1007/s10096-006-0159-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-006-0159-2